Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study

Multiple Sclerosis

Volumn 21, Issue 8, 2015, Pages 1013-1024

  Kuhle, J ^a   Disanto, G ^a   Dobson, R ^a   Adiutori, R ^a   Bianchi, L ^a   Topping, J ^a   Bestwick, J P ^a   Meier, U C ^a   Marta, M ^a   Dalla Costa, G ^c   Runia, T ^d   Evdoshenko, E ^e   Lazareva, N ^e   Thouvenot, E ^f,g   Iaffaldano, P ^h   Direnzo, V ^h   Khademi, M ⁱ   Piehl, F ⁱ   Comabella, M ^j   Sombekke, M ^k   Killestein, J ^k   Hegen, H ^l   Rauch, S ^l   Dalfonso, S ^m   Alvarez Cermeno J C ⁿ   Kleinova P ^o   Horakova D ^o   Roesler, R ^p   Lauda, F ^p   Llufriu, S ^q   Avsar, T ^r   Uygunoglu, U ^s   Altintas, A ^s   Saip, S ^s   Menge, T ^t   Rajda, C ^u   Bergamaschi, R ^v   Moll, N ^w   Khalil, M ^x   Marignier, R ^y   Dujmovic, I ^z   Larsson, H ^aa   Malmestrom, C ^ab   Scarpini, E ^ac   Fenoglio, C ^ac   Wergeland, S ^ad   Laroni, A ^ae   Annibali, V ^af   Romano, S ^af   Martinez A D ^ag   Carra, A ^ag   Salvetti, M ^af   Uccelli, A ^ae   Torkildsen, O ^ad   Myhr, K M ^ae   Galimberti, D ^ac   Rejdak, K ^ah   Lycke, J ^ab   Frederiksen, J L ^aa   Drulovic, J ^z   Confavreux, C ^y   Brassat, D ^ai   Enzinger, C ^x   Fuchs, S ^x   Bosca, I ^aj   Pelletier, J ^w   Picard, C ^w   Colombo, E ^v   Franciotta, D ^v   Derfuss, T ^b   Lindberg, R L P ^b   Yaldizli, O ^b   Vecsei L ^u   Kieseier, B C ^t   Hartung, H P ^t   Villoslada, P ^q   Siva, A ^s   Saiz, A ^q   Tumani, H ^p   Havrdova E ^o   Villar, L M ⁿ   Leone, M ^ak   Barizzone, N ^m   Deisenhammer, F ^l   Teunissen, C ^k   Montalban, X ^j   Tintore M ^j   Olsson, T ⁱ   Trojano, M ^h   Lehmann, S ^f,g   Castelnovo, G ^f,g   Lapin, S ^e   Hintzen, R ^d   Kappos, L ^b   Furlan, R ^c   Martinelli, V ^c   Comi, G ^c   Ramagopalan, S V ^al   Giovannoni, G ^a   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e City Clinical Hospital 31   (Russian Federation)

^f INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^g DEPARTMENT OF NEUROLOGY   (France)

^h UNIVERSITY OF BARI   (Italy)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^k VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^l INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^m UNIVERSITY OF EASTERN PIEDMONT   (Italy)

ⁿ HOSPITAL RAMÓN Y CAJAL   (Spain)

^o CHARLES UNIVERSITY   (Czech Republic)

^p UNIVERSITY OF ULM   (Germany)

^q HOSPITAL CLÍNIC   (Spain)

^r ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^s ISTANBUL UNIVERSITY   (Turkey)

^t HEINRICH HEINE UNIVERSITY   (Germany)

^u UNIVERSITY OF SZEGED   (Hungary)

^v C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^w TIMONE HOSPITAL   (France)

^x MEDICAL UNIVERSITY OF GRAZ   (Austria)

^y UNIVERSITÉ LYON 1   (France)

^z UNIVERSITY OF BELGRADE   (Serbia)

^aa UNIVERSITY OF COPENHAGEN   (Denmark)

^ab UNIVERSITY OF GOTHENBURG   (Sweden)

^ac UNIVERSITY OF MILAN   (Italy)

^ad UNIVERSITY OF BERGEN   (Norway)

^ae UNIVERSITY OF GENOA   (Italy)

^af SAPIENZA UNIVERSITY OF ROME   (Italy)

^ag HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^ah MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^ai UNIVERSITÉ DE TOULOUSE   (France)

^aj INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^ak AOU Maggiore della Carità   (Italy)

^al UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Clinically definite multiple sclerosis (CDMS); clinically isolated syndrome (CIS); Epstein Barr nuclear antigen 1 (EBNA 1); oligoclonal bands (OCBs); serum 25 hydroxyvitamin D3 (25 OH D)

Indexed keywords

CALCIFEDIOL; COTININE; EPSTEIN BARR VIRUS ANTIGEN 1; IMMUNOGLOBULIN G; OLIGOCLONAL BAND; NUCLEAR PROTEIN; SND1 PROTEIN, HUMAN; VITAMIN D;

ADULT; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COHORT ANALYSIS; CYTOMEGALOVIRUS; DEMYELINATING DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PATHOGENESIS; RISK FACTOR; VITAMIN BLOOD LEVEL; BLOOD; CEREBROSPINAL FLUID; CLINICAL TRIAL; DISEASE COURSE; GENETICS; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NUCLEAR PROTEINS; OLIGOCLONAL BANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; VITAMIN D;

EID: 84929479105     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514568827     Document Type: Article

References (32)

1. Compston A, Coles A,. Multiple sclerosis. Lancet 2002; 359: 1221-1231.
2. Ramagopalan SV, Dobson R, Meier UC,. Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010; 9: 727-739.
3. Miller DH, Chard DT, Ciccarelli O,. Clinically isolated syndromes. Lancet Neurol 2012; 11: 157-169.
4. Fisniku LK, Brex PA, Altmann DR,. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808-817.
5. Tintoré M, Rovira A, Río J,. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008; 70: 1079-1083.
6. Ascherio A, Munger KL, White R,. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71: 306-314.
7. Lunemann JD, Tintoré M, Messmer B,. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010; 67: 159-169.
8. Martinelli V, Dalla CG, Colombo B,. Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes. Mult Scler 2014; 20: 147-155.
9. Banwell B, Bar-Or A, Arnold DL,. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol 2011; 10: 436-445.
10. Miller DH, Weinshenker BG, Filippi M,. Differential diagnosis of suspected multiple sclerosis: A consensus approach. Mult Scler 2008; 14: 1157-1174.
11. Poser CM, Paty DW, Scheinberg L,. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
12. Freedman MS, Thompson EJ, Deisenhammer F,. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: A consensus statement. Arch Neurol 2005; 62: 865-870.
13. Link H, Tibbling G,. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397-401.
14. Teunissen CE, Petzold A, Bennett JL,. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009; 73: 1914-1922.
15. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C,. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77: 1435-1438.
16. Mowry EM, Krupp LB, Milazzo M,. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67: 618-624.
17. Tintoré M, Rovira A, Arrambide G,. Brainstem lesions in clinically isolated syndromes. Neurology 2010; 75: 1933-1938.
18. Disanto G, Morahan JM, Barnett MH,. The evidence for a role of B cells in multiple sclerosis. Neurology 2012; 78: 823-832.
19. Skov AG, Skov T, Frederiksen JL,. Oligoclonal bands predict multiple sclerosis after optic neuritis: A literature survey. Mult Scler 2011; 17: 404-410.
20. Tintoré M, Rovira A, Río J,. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008; 70: 1079-1083.
21. Mowry EM, Pesic M, Grimes B,. Clinical predictors of early second event in patients with clinically isolated syndrome. J Neurol 2009; 256: 1061-1066.
22. Welsh P, Peters MJ, Sattar N,. Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. Arthritis Rheum 2011; 63: 1763-1769.
23. Kamen DL, Tangpricha V,. Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity. J Mol Med (Berl) 2010; 88: 441-450.
24. Simon KC, Munger KL, Ascherio A,. Vitamin D and multiple sclerosis: Epidemiology, immunology, and genetics. Curr Opin Neurol 2012; 25: 246-251.
25. Kuhle J, Pohl C, Mehling M,. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007; 356: 371-378.
26. de Ory F, Guisasola ME, Sanz JC,. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections. Clin Vaccine Immunol 2011; 18: 444-448.
27. Pakpoor J, Disanto G, Gerber JE,. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: A meta-analysis. Mult Scler 2013; 19: 162-166.
28. Harbo HF, Isobe N, Berg-Hansen P,. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler 2014; 20: 660-668.
29. Imrell K, Landtblom AM, Hillert J,. Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct. Neurology 2006; 67: 1062-1064.
30. Sundqvist E, Sundström P, Lindén M,. Epstein-Barr virus and multiple sclerosis: Interaction with HLA. Genes Immun 2012; 13: 14-20.
31. Waubant E, Mowry EM, Krupp L,. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler 2013; 19: 891-895.
32. Polman CH, Reingold SC, Banwell B,. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.